日韩精品无码一区二区三区免费,在线观看欧美一区,高清国产免费观看,久久久久精品视频,免费观看国产小粉嫩喷水,久久播放无码专区

產(chǎn)品資料

PD 184352, Free Base **

如果您對該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: PD 184352, Free Base **
產(chǎn)品型號: LC P-8499
產(chǎn)品展商: 原裝進口
產(chǎn)品文檔: 無相關(guān)文檔

簡單介紹

PD 184352, Free Base **


PD 184352, Free Base **  的詳細介紹
PD 184352, Free Base **

產(chǎn)品名稱:PD 184352, Free Base
產(chǎn)品貨號:LC  P-8499
產(chǎn)品規(guī)格:10 MG
PD184352 is an inhibitor of mitogen activated protein kinase kinase (MEK or MAPKK).
Antitumor activity of PD184352 is evident in preclinical models, including pancreas, colon, and breast cancers, which are associated with its inhibition of pERK.  Allen, L.F., et al.  "CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)."  Semin. Oncol. 30:  105-116 (2003).
PD184352 profoundly inhibited the growth of, and induced apoptosis in, ovarian tumor cells with mutations in either KRAS or BRAF.  However, ovarian cancer cells containing wild-type sequences were not sensitive to PD184352.  Pohl, G., et al.  "Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations."  Cancer Res. 65:  1994-2000 (2005).
PD184352 inhibited C-Raf with an IC50 of 12 nM and inhibited more than 90% of ERK phosphorylation at a concentration of 10 nM.  In vivo, PD184352 decreased adenoma formation and significantly restored lung structure.  Kramer, B.W., et al.  "Use of mitogenic cascade blockers for treatment of C-Raf induced lung adenoma in vivo:  CI-1040 strongly reduces growth and improves lung structure."  BMC Cancer 4:  24 (2004).
PD184352 inhibited the MAPK pathway and induced apoptosis through a pathway involved in dephosphorylation, aggregation of Fas-associated death domain protein, and death receptor-independent caspase-8 activation.  Meng, X.W., et al.  "Central Role of Fas-associated Death Domain Protein in Apoptosis Induction by the Mitogen-activated Protein Kinase Kinase Inhibitor CI-1040 (PD184352) in Acute Lymphocytic Leukemia Cells in Vitro."  J. Biol. Chem. 278:  47326-47339 (2003).
However, PD184352 suffered from poor pharmacokinetics because of its low solubility and rapid clearance.  Barrett, S.D., et al.  "The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901."  Bioorg. Med. Chem. Lett. 18:  6501-6504 (2008).
Storage:  Store at or below -20 ºC.  Solubility:  Soluble in DMSO at 50 mg/mL; soluble in ethanol at 8.3 mg/mL with slight warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 5-10 µM buffers, serum, or other additives may increase or decrease the aqueous solubility.  Disposal:  A

產(chǎn)品留言
標題
聯(lián)系人
聯(lián)系電話
內(nèi)容
驗證碼
點擊換一張
注:1.可以使用快捷鍵Alt+S或Ctrl+Enter發(fā)送信息!
2.如有必要,請您留下您的詳細聯(lián)系方式!
使用指南 付款方式 客戶關(guān)懷 **與保密 法律幫助 服務條款 監(jiān)察中心信箱
分享到:

滬公網(wǎng)安備 31011002002623號